Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 135

    Unichem Labs gets tentative USFDA nod for generic version of JnJ Zyrtec-D 12 Hour

    Unichem Labs gets tentative USFDA nod for generic version of JnJ Zyrtec-D 12 Hour

    Farhat Nasim9 May 2019 10:15 AM IST
    Unichem Lab's approved drug is a generic copy of Zyrtec-D 12 Hour which is used for treating allergic rhinitis.New Delhi: Unichem Laboratories Tuesday...
    Lupin gets more time from Government to complete Indore SEZ project

    Lupin gets more time from Government to complete Indore SEZ project

    Farhat Nasim9 May 2019 10:01 AM IST
    The decision to give more time to Lupin for the completion of its project was taken by the Board of Approval (BoA) in its meeting on April 22 here....
    Novartis buys Takeda dry eye drug Xiidrafor for $3.4 billion

    Novartis buys Takeda dry eye drug Xiidrafor for $3.4 billion

    Garima9 May 2019 9:45 AM IST
    U.S: Swiss drugmaker Novartis AG said on Wednesday it agreed to acquire Takeda Pharmaceutical Company Ltd's dry eye drug Xiidrafor an upfront payment...
    Boston Scientific gets USFDA approval for VICI VENOUS STENT System

    Boston Scientific gets USFDA approval for VICI VENOUS STENT System

    Medical Dialogues Bureau9 May 2019 9:30 AM IST
    The approval of the VICI VENOUS STENT was based on data from the VIRTUS study, a prospective, multi-centre, single-arm study with 170 patients.New...
    Alphabets GV leads $58.5 million investment to launch Verve Therapeutics

    Alphabet's GV leads $58.5 million investment to launch Verve Therapeutics

    Garima9 May 2019 9:15 AM IST
    Verve Therapeutics plans to target adults at risk of coronary artery disease, the leading cause of death worldwide, by editing their genes to mirror...
    Vaccines saving millions in Somalia: Urgent need to scale up routine immunisation programme

    Vaccines saving millions in Somalia: Urgent need to scale up routine immunisation programme

    Medical Dialogues Bureau9 May 2019 9:00 AM IST
    Immunisation saves millions of lives every year and is widely recognized as one of the worlds most successful and cost-effective public health...
    Natco Pharma marketing partner gets USFDA approval for Nitroglycerin Sublingual Tablets

    Natco Pharma marketing partner gets USFDA approval for Nitroglycerin Sublingual Tablets

    Farhat Nasim8 May 2019 10:15 AM IST
    Nitroglycerin sublingual tablets are used to treat episodes of angina (chest pain) in people who have coronary artery disease (narrowing of the blood...
    Lupin gets tentative USFDA nod for Fosaprepitant injection

    Lupin gets tentative USFDA nod for Fosaprepitant injection

    Farhat Nasim8 May 2019 10:00 AM IST
    Fosaprepitant for injection is a generic version of Merck Sharp & Dohme Corp's Emend for injection in the same strength.New Delhi: Drug firm Lupin...
    Biocon commercial rights on biosimilar adalimumab extends to global markets

    Biocon commercial rights on biosimilar adalimumab extends to global markets

    Farhat Nasim8 May 2019 9:45 AM IST
    Biocon, under the terms of its global partnership with Mylan for monoclonal antibodies, retains its economic interest in this expanded in-licensing...
    Alembic Pharma partners with SPH Group, Adia for Chinese market

    Alembic Pharma partners with SPH Group, Adia for Chinese market

    Garima8 May 2019 9:30 AM IST
    SPH Sine, Alembic Pharma and Adia will hold 51 per cent, 44 per cent and 5 per cent equity in the JVA.Vadodara: City-based Alembic Pharmaceuticals has...
    Glenmark appoints Yasir Rawjee as CEO of Glenmark Life Sciences

    Glenmark appoints Yasir Rawjee as CEO of Glenmark Life Sciences

    Medical Dialogues Bureau8 May 2019 9:15 AM IST
    Yasir Rawjee joins Glenmark Life Sciences from Mylan, where most recently he was the Head of Global API Operations, Glenmark Pharmaceuticals said in a...
    Alembic Pharma JV gets EIR from USFDA for Karakhadi facility

    Alembic Pharma JV gets EIR from USFDA for Karakhadi facility

    Farhat Nasim7 May 2019 10:10 AM IST
    The EIR is for the inspection carried out by USFDA at Alembic Pharma's joint venture, Aleor Dermaceuticals' at Karakhadi, Gujarat, India during the...
    PrevNext

    Popular Stories

    Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore

    Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Lupin posts net loss at Rs 835 crore in Q3

    Lupin posts net loss at Rs 835 crore in Q3

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Biocon Biologics appoints M B Chinappa as Chief Financial Officer

    Biocon Biologics appoints M B Chinappa as Chief Financial Officer

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    FDA expands approval of Gilenya to treat multiple sclerosis in pediatric patients

    FDA expands approval of Gilenya to treat multiple sclerosis in pediatric patients

    FDA shuts six medical stores in Haryana due to irregularities

    FDA shuts six medical stores in Haryana due to irregularities

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok